McCormick & Company Inc
XMUN:MCX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
McCormick & Company Inc
XMUN:MCX
|
US |
|
Inovio Pharmaceuticals Inc
F:GBM
|
US |
|
GlobalData PLC
LSE:DATA
|
UK |
|
Raymond James Financial Inc
NYSE:RJF
|
US |
|
C
|
Cass Information Systems Inc
F:CC3
|
US |
|
O
|
Organon & Co
F:7XP
|
US |
|
Ipsos SA
F:IPZ
|
FR |
Wall St Price Targets
MCX Price Targets Summary
McCormick & Company Inc
According to Wall Street analysts, the average 1-year price target for MCX is 54.02 EUR with a low forecast of 44.49 EUR and a high forecast of 69.83 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MCX's stock price target?
Price Target
54.02
EUR
According to Wall Street analysts, the average 1-year price target for MCX is 54.02 EUR with a low forecast of 44.49 EUR and a high forecast of 69.83 EUR.
What is the Revenue forecast for McCormick & Company Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 3 years is 8%.
What is the Operating Income forecast for McCormick & Company Inc?
Projected CAGR
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 11%.
What is the Net Income forecast for McCormick & Company Inc?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 3 years is 8%.
